Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Labs will have to submit Z-Codes with every molecular pathology testing code billed to UnitedHealthcare, starting Aug. 1.
Free open-source software can be leveraged across diagnostic processes—how can your organization benefit from it?
What should pathology groups and labs do in order to attract and maintain clinical talent in today’s economy?
The new codes have garnered attention as a future mechanism for additional reimbursement and thus deserve further discussion.